TILDRAKIZUMAB for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 644 adverse event reports in the FDA FAERS database where TILDRAKIZUMAB was used for Psoriasis.
Most Reported Side Effects for TILDRAKIZUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Product dose omission issue | 53 | 6.1% | 7 | 12 |
| Death | 50 | 5.8% | 50 | 7 |
| Drug ineffective | 50 | 5.8% | 2 | 9 |
| Psoriasis | 37 | 4.3% | 3 | 12 |
| Urinary tract infection | 36 | 4.1% | 1 | 11 |
| Pneumonia | 33 | 3.8% | 3 | 22 |
| Off label use | 27 | 3.1% | 0 | 2 |
| Condition aggravated | 25 | 2.9% | 0 | 5 |
| Covid-19 | 25 | 2.9% | 3 | 15 |
| Inappropriate schedule of product administration | 22 | 2.5% | 3 | 6 |
| Cerebrovascular accident | 20 | 2.3% | 0 | 15 |
| Fatigue | 17 | 2.0% | 2 | 4 |
| Myocardial infarction | 17 | 2.0% | 4 | 11 |
| Cellulitis | 16 | 1.8% | 0 | 6 |
| Pruritus | 16 | 1.8% | 1 | 6 |
Other Indications for TILDRAKIZUMAB
Product used for unknown indication (176)
Psoriatic arthropathy (30)
Hidradenitis (8)
Lichen planus (6)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)